(Q43280102)

18 November 2017

Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia (English)

1 reference

18 November 2017

1 reference

1 reference

Mahmut Bulut

1

1 reference

18 November 2017

Haluk Asuman Savas

2

1 reference

18 November 2017

Abdurrahman Altindag

3

1 reference

18 November 2017

Osman Virit

4

1 reference

18 November 2017

Alican Dalkilic

5

1 reference

18 November 2017

1 January 2009

1 reference

World Journal of Biological Psychiatry

18 November 2017

1 reference

18 November 2017

10

1 reference

18 November 2017

4 Pt 2

1 reference

18 November 2017

626-628

1 reference

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

18 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

The NMDA receptor hypofunction model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

N-acetylcysteine abrogates acute lung injury induced by endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Possible mechanisms of neurodegeneration in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Possible role of nitric oxide and adrenomedullin in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970903144004

10.1080/15622970903144004

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference